Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Munn

Showing results (51-60 of 150) with videos related to

Pageof 15
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 29, 2009
IDO activates regulatory T cells and blocks their conversion into Th17-like T cellsBabak Baban, Phillip R Chandler, Madhav D Sharma, et al.
The Biochemical Journal|June 5, 2008
Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapySenthil Karunakaran, Nagavedi S Umapathy, Muthusamy Thangaraju, et al.
Blood|December 14, 2007
Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethalityLisa K Jasperson, Christoph Bucher, Angela Panoskaltsis-Mortari, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 12, 2014
TLR2-dependent activation of β-catenin pathway in dendritic cells induces regulatory responses and attenuates autoimmune inflammationIndumathi Manoharan, Yuan Hong, Amol Suryawanshi, et al.
Cell Reports|September 29, 2015
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent MannerRikke B Holmgaard, Dmitriy Zamarin, Yanyun Li, et al.
Journal for Immunotherapy of Cancer|April 5, 2025
β-blocker suppresses both tumoral sympathetic neurons and perivascular macrophages during oncolytic herpes virotherapyKonstantina Kyritsi, Rafal Pacholczyk, Eugene Douglass, et al.
Journal for Immunotherapy of Cancer|October 14, 2020
p50 suppresses cytotoxic T lymphocyte effector function to regulate tumor immune escape and response to immunotherapyChunwan Lu, John D Klement, Alyssa D Smith, et al.
Molecular and Cellular Biology|November 20, 2013
GCN2-dependent metabolic stress is essential for endotoxemic cytokine induction and pathologyHaiyun Liu, Lei Huang, Jillian Bradley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansionAndrew L Mellor, Babak Baban, Phillip Chandler, et al.
International Immunology|June 22, 2005
A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligationBabak Baban, Anna M Hansen, Phillip R Chandler, et al.
Pageof 15

Showing results (51-60 of 150) with videos related to

Sort By:
Pageof 15
Journal of Immunology (Baltimore, Md. : 1950)|July 29, 2009
IDO activates regulatory T cells and blocks their conversion into Th17-like T cellsBabak Baban, Phillip R Chandler, Madhav D Sharma, et al.
The Biochemical Journal|June 5, 2008
Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapySenthil Karunakaran, Nagavedi S Umapathy, Muthusamy Thangaraju, et al.
Blood|December 14, 2007
Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethalityLisa K Jasperson, Christoph Bucher, Angela Panoskaltsis-Mortari, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 12, 2014
TLR2-dependent activation of β-catenin pathway in dendritic cells induces regulatory responses and attenuates autoimmune inflammationIndumathi Manoharan, Yuan Hong, Amol Suryawanshi, et al.
Cell Reports|September 29, 2015
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent MannerRikke B Holmgaard, Dmitriy Zamarin, Yanyun Li, et al.
Journal for Immunotherapy of Cancer|April 5, 2025
β-blocker suppresses both tumoral sympathetic neurons and perivascular macrophages during oncolytic herpes virotherapyKonstantina Kyritsi, Rafal Pacholczyk, Eugene Douglass, et al.
Journal for Immunotherapy of Cancer|October 14, 2020
p50 suppresses cytotoxic T lymphocyte effector function to regulate tumor immune escape and response to immunotherapyChunwan Lu, John D Klement, Alyssa D Smith, et al.
Molecular and Cellular Biology|November 20, 2013
GCN2-dependent metabolic stress is essential for endotoxemic cytokine induction and pathologyHaiyun Liu, Lei Huang, Jillian Bradley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansionAndrew L Mellor, Babak Baban, Phillip Chandler, et al.
International Immunology|June 22, 2005
A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligationBabak Baban, Anna M Hansen, Phillip R Chandler, et al.
Pageof 15